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Ceramic scaffolds have been widely used in biomedical application to treat bone defects. 
Enhancing the ceramic scaffold by using polymeric materials as coating may improve their 
strength however it will alter their pore characteristic as well as degradation behaviour 
which is crucial for the success of scaffold requirement. Polyhydroxybutyrate-co-valerate 
(PHBV) is degradable and has excellent compatibility properties for biomaterials. Thus the  
objectives of this study are (i)  to determine the sintering temperature for the fabrication by 
using polymeric sponge method (ii) to analyse the effect of PHBV coated Tricalcium (TCP) 
scaffold after in-vitro immersion in simulated body fluid (SBF) solution for 16 weeks (iii) 
to evaluate the bioactivity and biocompatibility of the PHBV coated TCP scaffolds. 
Polyhydroxybutyrate-co-valerate (PHBV) coated TCP scaffolds were fabricated using  
polymeric sponge method. Two types of calcium phosphate (CaP) were used as matrix 
which are commercial (C-CP) and locally (L-TCP) supplied. The CaP scaffolds were 
sintered at optimised sintering temperature of 1450°C. The initial mechanical strength of 
the commercial and  in-house TCP scaffolds are 36.64 KPa and 10.06 KPa respectively. 
The ceramic scaffold were then coated with PHBV using dip coating method, resulting in  
the increased of the  compression strength to 140.00 KPa (PHBV coated C-CP) and 148.00 
KPa ( PHBV coated L-TCP) respectively. The scaffold contained interconnect pores with 
a range of size from 200 to 400µm, and porosity  within 81% to 83%. Their mechanical 
strength in simulated body fluid (SBF) solution was retained up to 12 weeks with good pore 
integrity structure. The formation of bone-like apatite in the shape of globular and 
cauliflower-like cluster was observed  after 4 weeks of immersion  in SBF solution. The 
presence of apatite mineral was confirmed by FTIR, XRD and EDX analysis indicating 
bioactive ability of the scaffold. Biocompatibility analysis shows that the scaffolds were 
able to retain Saos-2 cells after 24 hours indicating their ability to allow cells proliferation  
to adhere to it. The increasing cell  metabolic activity up to day 14 was also observed 
suggested that the scaffold is compatible with cells and non toxic. This finding has indicated  
that the PHBV coated TCP scaffold is a compatible and comparable material that is 











Perancah seramik telah digunakan secara meluas di dalam bidang perubatan bio untuk 
merawat kecacatan tulang. Polyhydroxybutyrate-co-valerate (PHBV) adalah bahan 
polimer yang boleh terurai dan memiliki sifat keserasian yang baik untuk digunakan 
sebagai bahan bio perubatan. Kekuatan perancah seramik boleh ditingkatkan dengan 
menyadurnya menggunakan bahan polimer, tetapi ini akan mengubah sifat liang serta sifat 
keserasian perancah yang mana ianya amat penting dalam memastikan kejayaannya 
sewaktu proses penggunaan. Oleh itu, objektif kajian ini adalah untuk menentukan suhu 
pembakaran perancah menggunakan kaedah replikasi span polimer, untuk menilai kesan 
tempoh perendaman in-vitro di dalam larutan cecair simulasi badan terhadap sifat 
mekamikal  perancah trikalsium (TCP) bersalut PHBV dan untuk menilai sifat bioaktif dan 
sifat keserasian perancah TCP bersalut PHBV. Perancah TCP yang disaluti lapisan PHBV 
telah dihasilkan dengan menggunakan kaedah replikasi span polimer. Dua jenis bahan 
mentah kalsium fosfat (CaP) digunakan sebagai matrik iaitu bergred komersial (C-CP) 
dan tempatan (L-TCP). Perancah CaP dibakar pada suhu optimum iaitu 1450°C. Kekuatan 
mekanikal permulaan perancah  TCP komersial dan tempatan adalah 36.64 KPa dan 10.06 
KPa. Perancah seramik kemudiannya disalut dengan PHBV dengan menggunakan kaedah 
penyalutan celup. Penyalutan ini meningkatkan kekuatan mampatan perancah kepada 
140.00 KPa dan 148.00 KPa bagi perancah C-TCP bersalut PHBV  dan L-TCP bersalut 
PHBV. Perancah TCP bersalut PHBV memiliki liang saling bersambung yang bersaiz di 
dalam lingkungan 200 - 400μm, dan peratusan  keliangan 81% hingga 83%. Kekuatan  
mekanikal dan struktur liang perancah  sewaktu rendaman in-vitro di dalam SBF adalah 
bertahan dengan baik sehingga minggu ke- 12. Longokan apatit dalam bentuk global dan  
bunga kubis terhasil seawal 4 minggu semasa proses rendaman. Kehadiran mineral apatit 
ini dicirikan dengan menggunkaan FTIR, XRD dan EDX yang mana mengesahkan 
kebolehan sifat bioaktif perancah. Analisis sifat keserasian menunjukkan bilangan sel jenis 
Saos-2 kekal selepas 24 jam proses pengkulturan, membuktikan keupayaan perancah di 
dalam membantu percambahan sel. Peningkatan aktiviti metabolik sel sehingga hari ke-14 
juga diperhatikan menunjukkan keserasian perancah di dalam menampung kehidupan sel 
dan tidak toksik kepadanya. Dapatan ini menunjukkan bahawa perancah TCP bersalut  
PHBV adalah serasi dan setanding dengan sifat tulang manusia dan memiliki potensi yang 
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The introduction presented in the thesis are classified into 6 sub-chapter including 
background, problem statement, objectives, research scope, significance of study and 
structure of thesis. 
 
1.1 Background  
In the field of bone tissue engineering, further research has been conducted for the 
past decades to achieve the best condition in term of materials as well as processing 
techniques to improve their application (Li et. al., 2013). As the results, materials used for 
porous scaffold which is suitable for bone healing and structural support with optimum 
osteogenesis abilities was accomplished. Throughout bone tissue regeneratqaion, bone 
scaffold act as a template. Nowadays, besides controlling the porosity of porous scaffold 
during fabrication process technologies being used also improve the properties of the 
scaffold. The uniqueness of natural human bone, they are associate of both mechanical 
properties and architectural design form macroscale to nano scale dimension as shown in 
Figure 1.1. However, the porous scaffold should imitate the natures of the bone to have the 
desired physical properties, mechanical strength and biological properties. It also must be 
biocompatible with the host tissue and able to support proliferation, adhesion and secretory 





Figure 1.1:  Macro to nano scale of bone cell (Li et. al., 2013) 
 
The loss of severely damaged bone are replace through substitution either 
autologous or allogenic as an alternative method. This is the important aspects in 
regenerative medicine. The most notable studied, clinically tested and used synthetic 
materials based on calcium phosphate (CaP) are hydroxyapatite (HAp- Ca10(PO4)6(OH)2), 
β-tricalcium phosphate (β-TCP – Ca3(PO4)2), and biphasic HAp/β-TCP mixture. CaP with 
high biocompatibility and bioactivity of CaP thus, make it the best candidate to fabricate 
porous scaffold. Otherwise, it also builds a connection between ceramic implant and bone 
tissue (Ge et. al., 2008). Besides that, in human healthcare, one of the most expensive cost 
involving tissue and organ failures which might be caused from infections, injuries and 
defects. And the core reason towards this problem is lack of organ and tissue donor. 
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Therefore, the solution that been discovered to encounter this issue is by introducing 
artificial substitutes and non-living processed tissues (Rai et. al., 2012). Though, the flaw 
of the bone or the outcome of the host tissue are not really solved by the substitutes such 
as lack of biocompatibility, non-bioactive material, vascularization of bone and bone 
remodeling (Roche et. al., 2015). Therefore, for a better result bioactive, biodegradable and 
biocompatible materials is a must being used in the field of tissue engineering (TE) (Puppi 
et. al., 2010).  
There are gained in global interest of orthophosphate-based ceramics in orthopedics 
fixation because of the similar composition between mineral phase in human bone which 
promote organization of bone cell of the implants, hence they are the best alternative 
candidates over bio-inert materials such as chromium, cobalt, stainless steel and titanium.  
Within this TE field, β-TCP and HA are the most studied materials due to their greater 
biocompatibility and biodegradability compared to other biomaterials. However, when it 
comes to biodegradable composite, β-TCP are the most favored choice as in order to 
accommodate new bone formation because its resorption rate is better than other 
biomaterials.   
Within regenerative medicine and tissue engineering, there are a lot of natural and 
synthetic polymer being used. However, according to Nair and Laurencin (2007) natural  
polymers has been considered to be among the first used for clinical application. According 
to Tang et. al. (2014), natural polymers include cellulose, chitin, silk, hyaluronic acid, 
chitosan, gelatin, albumin, collagen, keratin, elastin and actin. Nevertheless, because of 
their structural complexity, possible immunogenicity, and inferior biomechanical 
properties make they difficult to be used. In order to avoid the weaknesses of natural 
polymer, the potential candidates in tissue engineering which is synthetic polymer has been 
introduced. Synthetic polymer not only easy to tailor to any form for tissue engineering but 
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they also easy to get compared to natural polymers. In tissue engineering and regenerative 
medicine field, major synthetic polymers used are polycaprolactone (PCL), poly(ethylene 
glycol) (PEG), poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(lactide-co-glycolic 
acid) (PLGA), polyhydroxybutyrate (PHB), poly(hydroxyvalerate) (PHV), 
poly(hydroxybutyrate- valerate) (PHBV), poly(dioxanone) (PDS), poly(propylene 
fumarate) (PPF), polyurethanes (PUs), polyphosphazenes, polyanhydrides, and polyacetals 
(Tang et. al., 2014). 
 
1.2 Problem statement 
A lot of efforts have been dedicated over the past decades in the development of 
biodegradable scaffolds which mimicking natural bone tissues in term of excellent 
biocompatibility as well as mechanical properties (Holland et. al., 2005; Wagoner-johnson 
et. al., 2011). As an example, according to Kang et. al. (2011), the widely studied of HA 
and β-TCP are to endeavor the strong biocompatibility, biodegradability, desire 
compressive strength of ceramics and flexibility of ductile polymers. Nevertheless, there 
are several methods involving in strengthening the mechanical strength of composites 
scaffold and one of them is polymer matrix approach as well as self-assembled mineralized 
collagen method (Fabbri et. al., 2010). Though by using these methods, the amount of 
ceramic matrix being used is limited hence, the composite’s bioactivity will be affected 
(Bleach et. al., 2002). As instance, by increasing 10% to 40% volume of calcium phosphate 
which is HA, the materials become fragile so, to overcome the problem the HA content will 
be limited to 20% volume (Tan et. al., 2003). As a consequence, to improve the bioactivity 
properties, HA is being introduced with polymer to form a nanocomposite layers on the 
ceramic matrix (Roohani et. al., 2010) but, this method did not show in improving the 
strength of monolithic polymer also difficult to produce with high concentration of ceramic 
